EXOSOMES TELL THE STORY
LIVE

Serial Number

98200848

Owner

XZOM, INC.

Attorney

Gina Durham, Esq.

Filing Date

Sep 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EXOSOMES TELL THE STORY Trademark

Serial Number: 98200848

EXOSOMES TELL THE STORY is a trademark filed by XZOM, INC. on September 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

XZOM, INC.

9381 JUDICIAL DRIVE, SUITE 120
SAN DIEGO, CA 92121

Entity Type: 03

Biological Dynamics, Inc.

9381 Judicial Drive, Suite 120
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

September 27, 2023

Registration Date

Not Registered

Published for Opposition

March 26, 2024

Goods & Services

Medical testing for diagnostic and treatment purposes

diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes and other extra-cellular vesicles for use in disease detection, namely, autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; medical diagnostic reagents and assays for testing of exosomes and other extra-cellular vesicles in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders

Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; medical diagnostic apparatus for detecting autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; medical diagnostic apparatus, namely, lab-on-a-chip systems comprised of microelectrode arrays and microfluidic controllers, pumps, and valves for use in biological analysis; apparatus for carrying out diagnostic cell-based testing for medical purposes; diagnostic apparatus for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, namely, medical diagnostic apparatus for testing cell-derived vesicles or extra-cellular vesicles and detecting autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 3, 2026 EXRA
SOU EXTENSION 4 GRANTED
Feb 2, 2026 EX4G
SOU EXTENSION 4 FILED
Feb 2, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 2, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 7, 2025 EX3G
SOU EXTENSION 3 FILED
Nov 7, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 7, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 22, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 22, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 6, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 6, 2025 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 27, 2024 ASGN
SOU EXTENSION 1 FILED
Nov 21, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 21, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 19, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 19, 2024 COAR
WITHDRAWAL OF ATTORNEY GRANTED
Aug 20, 2024 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Aug 20, 2024 WOAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 21, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 14, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 14, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 14, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 14, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 13, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 11, 2023 NWOS
NEW APPLICATION ENTERED
Sep 30, 2023 NWAP